Did OM1 just prove AI-powered real-world evidence can survive FDA scrutiny?
FDA-grade evidence is getting bigger and harder to collect. OM1’s Hologic study shows how AI may change medtech submissions.
FDA-grade evidence is getting bigger and harder to collect. OM1’s Hologic study shows how AI may change medtech submissions.
Regulatory teams need speed, but AI needs auditability. Zifo’s authoring platform tests whether pharma can have both.